Human Tissue Therapy, as we use that term on this website, are minimally manipulated cells and tissues intended for homologous use only. None of the mentioned statements have been evaluated by the FDA. As defined in 21 CFR 1271.3(c), homologous use means the repair, reconstruction, replacement, or supplementation of a recipient’s cells or tissues with an HTT/P that performs the same basic function or functions in the recipient as in the donor. Human Tissue Therapies are not intended to diagnose, treat, cure or prevent any disease including COVID-19.
Human Tissue Therapy, as described on this website are not considered to be standard of care for any conditions or diseases.
Extremity Care offers insurance verification as an information service only. Information gathered during the requested research will be provided by the insurer or third-party payer. Results of this research are not a guarantee of coverage or reimbursement in the future. Extremity Care disclaim liability for payment of any claims, benefits, or costs.
Extremity Care does not guarantee payment, nor does insurance verification guarantee payment. Terms & Conditions apply. Extremity Care does not warrant the accuracy of the information provided. None of the content on this website should be interpreted as billing or reimbursement advice.